Viewing nowCombinationEmpagliflozin and Sitagliptin Tablets 10/100 mg
Empagliflozin 10mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.

MFDS item code 202501433 · Approved 2025.06.12
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in conjunction with meal and exercise therapy to assist adult patients with type 2 diabetes mellitus in controlling blood sugar levels by combining empagliflozin and sitagliptin. It effectively acts on individuals requiring blood sugar management to help improve blood sugar levels. This can lead to positive outcomes in managing diabetes for patients.
The recommended starting dose of this medicine is empagliflozin 10 mg/sitagliptin 100 mg once daily. For patients who tolerate empagliflozin 10 mg/sitagliptin 100 mg but require additional glycemic control, the dose of this medicine may be increased to empagliflozin 25 mg/sitagliptin 100 mg once daily. Patients switching from combination therapy with empagliflozin and sitagliptin to this medicine should take the same doses as before. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Patients with renal impairment The efficacy and safety of this medicine depend on renal function, and dosage adjustment based on renal function is required. Therefore, assessment of renal function is recommended before starting this medicine and periodically thereafter. No dosage adjustment is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. Do not administer this medicine if creatinine clearance (CrCl) is less than 45 ml/min or estimated glomerular filtration rate (eGFR) is less than 45 ml/min/1.73m2. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication may rarely cause serious allergic reactions, so if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur, treatment should be stopped immediately and a doctor consulted. Additionally, there is a risk of pancreatitis, which means inflammation of the pancreas, so if symptoms such as abdominal pain, nausea, or vomiting occur, healthcare professionals should be informed right away. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients with decreased kidney function may experience reduced efficacy or an increased risk of side effects, so regular kidney function tests should be conducted before and during treatment, and it is advisable not to use this medication in cases of severe kidney impairment. During treatment with this medication, there may be a risk of hypoglycemia if combined with other medications that have strong blood sugar-lowering effects, so careful monitoring of blood sugar levels is necessary, and adjustments in the dosage of other medications may be needed. Elderly patients or those prone to reduced fluid volume should be cautious of side effects such as dehydration or hypotension and may also need to temporarily stop taking this medication in cases of fluid loss, especially due to diarrhea or vomiting. This medication may increase the risk of urinary tract infections and genital fungal infections, so prompt treatment should be sought if infection symptoms appear. Care should be taken while driving or operating machinery, particularly in cases of concomitant use with insulin or sulfonylureas to avoid hypoglycemia. Pregnant or breastfeeding women should avoid taking this medication, and if pregnancy is confirmed, immediate consultation with a physician to discontinue use is recommended. This medication is not recommended for children under 18, as its safety and efficacy have not been established. In cases of overdose, there are no specific antidotes, so it is important to receive appropriate treatment based on symptoms. Finally, this medication should be kept out of reach of children, and it is safer not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This way, the effectiveness of the medication can be safely maintained.
Orange round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 10mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 25mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Dae Won Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.